Drug Shortage Report for MINT-SPIRONOLACTONE
| Report ID | 131333 |
| Drug Identification Number | 02488159 |
| Brand name | MINT-SPIRONOLACTONE |
| Common or Proper name | Spironolactone |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SPIRONOLACTONE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 count bottle |
| ATC code | C03DA |
| ATC description | POTASSIUM-SPARING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-11 |
| Estimated end date | 2021-03-31 |
| Actual end date | 2021-03-31 |
| Shortage status | Resolved |
| Updated date | 2021-04-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-04-05 | French | Compare |
| v4 | 2021-04-05 | English | Compare |
| v3 | 2021-01-12 | English | Compare |
| v2 | 2021-01-11 | French | Compare |
| v1 | 2021-01-11 | English | Compare |
Showing 1 to 5 of 5